{"id":19056,"date":"2022-01-14T10:25:05","date_gmt":"2022-01-14T09:25:05","guid":{"rendered":"https:\/\/www.idisantiago.es\/grupo-de-investigacion\/ac01-procesos-linfoproliferativos\/"},"modified":"2026-03-24T13:35:15","modified_gmt":"2026-03-24T12:35:15","slug":"ac01-procesos-linfoproliferativos","status":"publish","type":"project","link":"https:\/\/www.idisantiago.es\/en\/grupo-de-investigacion\/ac01-procesos-linfoproliferativos\/","title":{"rendered":"AC01 &#8211; Translational Hematology and Advanced Therapies"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||||false|false&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; custom_padding=&#8221;0px||||false|false&#8221; locked=&#8221;on&#8221; collapsed=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>\u00c1REA: <a href=\"https:\/\/www.idisantiago.es\/en\/research-areas-2\/a001-oncologia\/\">ONCOLOG\u00cdA<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;2_3,1_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/www.idisantiago.es\/wp-content\/uploads\/2021\/11\/grupo_investigacion.jpg&#8221; title_text=&#8221;Corporate portrait of office workers and employees&#8221; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_toggle title=&#8221;Objectives and lines of research&#8221; admin_label=&#8221;Objetivos y l\u00edneas de investigaci\u00f3n&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Objectives<\/h3>\n<p>The overall goal is to improve knowledge and treatment of blood diseases, as well as the development of advanced therapies using blood cells.<br \/>The group is open to research in all areas of hematologic diseases, including oncohematology, anemia, coagulation disorders, platelet disorders, and hemotherapy. In the field of advanced therapies with blood cells, it will develop lines of work aimed at therapeutic use both for blood diseases and in other areas of medicine.<\/p>\n<p><strong>Specific Objectives<\/strong><\/p>\n<ul>\n<li>Promote clinical trials with drugs for blood diseases<\/li>\n<li>Promote clinical trials involving cell therapies (hematopoietic stem cells, lymphocytes, mesenchymal cells, and other cell lines) for blood diseases and other medical fields<\/li>\n<li>Support registries of blood diseases and therapy outcomes<\/li>\n<li>Integrate morphological and genetic diagnoses with treatment strategies<\/li>\n<li>Translate the results of clinical trials into clinical practice<\/li>\n<li>Contribute to a better understanding of rare blood diseases<\/li>\n<li>Collaborate with other research groups at IDIS, the University, and national or international scientific associations in the field of blood diseases<\/li>\n<li>Collaborate with the pharmaceutical industry in the development of new therapies<\/li>\n<li>Collaborate with patient associations for hematologic diseases<\/li>\n<\/ul>\n<h3>Research Lines<\/h3>\n<ul>\n<li>Cell therapy in lymphoproliferative diseases and myeloma<\/li>\n<li>Cell therapy in autoimmune rheumatologic diseases<\/li>\n<li>New targets in myeloid disorders<\/li>\n<li>New platforms for cell therapy using blood cells<\/li>\n<li>Registries in cell therapy, hematopoietic stem cell transplantation, and various hematologic conditions<\/li>\n<\/ul>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Research team&#8221; admin_label=&#8221;Equipo investigador&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<table style=\"width: 100%; border-collapse: collapse; border-style: hidden; height: 405px;\" border=\"0\">\n<tbody>\n<tr style=\"height: 405px;\">\n<td style=\"width: 50%; height: 405px;\"><strong>Leader<\/strong><br \/>P\u00e9rez Encinas, Manuel Mateo<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Members<\/strong><br \/>Aliste Santos, Carlos<br \/>Alonso Vence, Natalia<br \/>Antelo Rodr\u00edguez, Beatriz<br \/>Benda\u00f1a L\u00f3pez, \u00c1ngeles<br \/>Cid L\u00f3pez, Miguel<br \/>D\u00edez L\u00e1zaro, Francisco Javier<br \/>Gonz\u00e1lez P\u00e9rez, Marta Sonia<br \/>N\u00fa\u00f1ez Quintela, V\u00edctor<br \/>Iglesias Fern\u00e1ndez, Alba<br \/>L\u00f3pez Espinosa, Elena<br \/>Silva Carbajales, Sof\u00eda<\/p>\n<p>&nbsp;<\/p>\n<\/td>\n<td style=\"width: 50%; height: 405px;\">\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Projects&#8221; disabled_on=&#8221;on|on|on&#8221; admin_label=&#8221;Proyectos (cambiar s\u00f3 codigo IDIS)&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; disabled=&#8221;on&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Publications&#8221; disabled_on=&#8221;on|on|on&#8221; admin_label=&#8221;Publicaciones&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<ul>\n<li>Publicaci\u00f3n 1<\/li>\n<li>Publicaci\u00f3n 2<\/li>\n<li>Etc.<\/li>\n<\/ul>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Group website&#8221; disabled_on=&#8221;on|on|on&#8221; admin_label=&#8221;Web del grupo&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;]https:\/\/[\/et_pb_toggle][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text admin_label=&#8221;Investigador\/a l\u00edder&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_2_text_align=&#8221;left&#8221; header_2_text_color=&#8221;#FFFFFF&#8221; background_color=&#8221;#10294c&#8221; custom_margin=&#8221;0px||||false|false&#8221; custom_padding=&#8221;6px||0px|6px|false|false&#8221; locked=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Lead researcher<\/h2>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;WP Team (cambiar s\u00f3 a ID pola do l\u00edder de equipo)&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div class=\"sp-wp-team-pro-wrapper wp-team-pro-preloader\" >\n\n<div id=\"sptp-41094\" class=\"sp-team-pro sptp-section sptp-new_page pagination_normal sptp-even\" >\n\n\t<div class=\"sp-team-pro-page-loading-image\"><\/div>\n<\/div>\n<\/div>\n\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00c1REA: ONCOLOG\u00cdAObjectives The overall goal is to improve knowledge and treatment of blood diseases, as well as the development of advanced therapies using blood cells.The group is open to research [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":10311,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"project_category":[512],"project_tag":[],"class_list":["post-19056","project","type-project","status-publish","has-post-thumbnail","hentry","project_category-oncologia-en"],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/project\/19056","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/comments?post=19056"}],"version-history":[{"count":38,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/project\/19056\/revisions"}],"predecessor-version":[{"id":45792,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/project\/19056\/revisions\/45792"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/media\/10311"}],"wp:attachment":[{"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/media?parent=19056"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/project_category?post=19056"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/project_tag?post=19056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}